Preparing pharmacists for mental health and addiction care

The future of pharmacy education: integrating mental health and addiction training means preparing students to meet needs that sit well beyond dispensing. Pharmacists routinely encounter medicines used for depression, anxiety, psychosis, sleep disturbance and substance use disorders. With the right knowledge and support, they can improve treatment safety, identify concerns early and connect people with appropriate care.

This work is especially important in community pharmacy, where visits are frequent and care is not confined to a consulting room. A person collecting repeat medication may describe escalating anxiety, alcohol use, insomnia or a crisis at home. Training must equip pharmacists to respond without judgement, recognise when further assessment is needed and work within their professional boundaries.

Australia makes the need particularly clear. In Melbourne, Sydney and Brisbane, community pharmacies form part of dense networks of general practice, hospitals and community mental health services. In Dubbo, Alice Springs and other regional or remote locations, workforce shortages, transport, limited local specialist services and unreliable broadband can make that same network much harder to reach.

An Australian response must fit the local system: the Pharmaceutical Benefits Scheme, Medicare-supported mental health care, the National Disability Insurance Scheme and state and territory regulation. It must also respect the role of Aboriginal Community Controlled Health Organisations and local cultural protocols. The task for educators is to build knowledge, clinical judgement and respectful communication while giving students clear pathways for referral.

Building clinical confidence from the start

A strong curriculum develops these capabilities across the whole degree, rather than confining them to an elective placement. Foundational learning can cover the pharmacology of psychiatric medicines and the relationship between mental health, alcohol and other drug use, social circumstances and medication safety. Later opportunities should let students interpret clinical scenarios, review complex regimens and discuss treatment options with supervised pharmacists and prescribers.

Communication training should include motivational interviewing, brief intervention techniques, trauma-informed care and responses to stigma. Simulated encounters can present a young person misusing a stimulant, an older adult affected by a fall and sedative use, or a patient distressed by voices and reduced insight. Students need practice in asking direct safety questions, setting boundaries and arranging urgent help. Australia’s 24-hour Suicide Prevention Lifeline on 13 11 14 provides one referral resource, while emergencies and acute suicide risk require local emergency pathways, including 000.

Physical health, substance use and mental illness often affect one another. Pharmacists should be able to discuss metabolic monitoring for some antipsychotics, sedation with psychotropics, interactions with alcohol and opioid medicines, and the complexities of polypharmacy. They also need a sound understanding of opioid agonist treatment, take-home naloxone, accidental overdose and relapse prevention. Affordability can shape whether prescribed medicines are taken, particularly for people relying on the Pharmaceutical Benefits Scheme. These subjects belong in routine medication review, not in a separate chapter labelled “addiction”.

Learning alongside communities and consumers

People with lived experience of mental illness, addiction, recovery or suicide bereavement should help shape how learning is designed and delivered. This includes selecting cases, reviewing scenarios and discussing what respectful care feels like. Contributors need payment, preparation and a choice about how their story is used. A consumer advisory group can prevent education from treating consumers as teaching material while offering no influence over the curriculum.

Placement design matters just as much. Students in regional services can learn how medicines supply, referral pathways and follow-up differ from metropolitan settings. The lessons are harder to extract when a university sends students into a community for the convenience of a placement and leaves local staff to manage the extra workload. Rural preceptors require funded time, supervision and access to continuing professional development. Telepharmacy can support this work, but its value depends on relationships, local protocols and clinical governance, as discussed in telepharmacy in rural communities.

Cultural safety should be assessed as a core competency. Aboriginal and Torres Strait Islander health should be taught with local Aboriginal health professionals, including staff of Aboriginal Community Controlled Health Organisations, and with appropriate input about the 7150 health assessment. There is no single pathway for every community, nor should education assume one set of experiences. Understanding 7150 medication and health outcomes, local referral routes and the limits of a short placement gives students a better basis for safe practice.

Pharmacists also need to know how a GP mental health treatment plan can open Medicare-supported psychology care for eligible people, while an NDIS plan may include psychology and psychosocial supports. They should understand who is involved, what documentation travels and how to make a useful referral. Clear relationships with local crisis, mental health and alcohol and other drug services make those pathways work.

Digital care without losing human connection

Telemedicine and telepharmacy have become important parts of rural service design, but technology changes access rather than replacing clinical relationships. A broader look at evidence on telemedicine shows benefits alongside concerns about privacy, workflow and unequal access. A pharmacist working remotely still needs a safe consultation space, a reliable connection, consent for information sharing and a route to escalate concerns. For an Aboriginal or Torres Strait Islander patient, the choice between video, telephone and face-to-face care should respect preference and community guidance.

Australia’s ePrescribing, electronic dispensing and My Health Record infrastructure can support continuity, particularly when someone moves between a hospital, a general practice and a community pharmacy. Shared records help pharmacists check allergies, interactions and recent changes. They do not remove the need for a conversation: people may not understand a new diagnosis, may have stopped a medicine or may face language and accessibility barriers. Shared access must also account for consent, appropriate information and the limits of what a dispensing record can reveal.

Discharge is another point where education can improve continuity. Research on post-discharge medication support shows why community pharmacists need an accurate summary, an accessible contact pathway and time to reconcile medicines with what the patient is actually using. A person may leave hospital with several changes and return to a previous medicine because the new routine was confusing. A structured review can identify omissions, affordability problems and adverse effects, then communicate them to the treating team.

Turning learning into accountable competence

Curriculum content matters only when students are held accountable for applying it. Under the national accreditation framework administered by the Australian Pharmacy Council, graduate outcomes should connect knowledge, professional communication, medicines management and collaboration to observable tasks. The intern year then provides a workplace setting in which these expectations can be reinforced, with appropriate support for preceptors and access to referral options when a problem falls outside a student’s role.

Assessment can use simulated consultations, case-based discussions, observed medication reviews and supervised workplace assessments. A student who can recite warning signs has not yet demonstrated that they can identify risk, discuss a sensitive issue and make a safe referral. Assessment standards should specify the performance required at each stage, offer multiple opportunities to improve and protect the validity of results for people from different educational and cultural backgrounds.

Evaluation should follow beyond examination scores. Useful measures include the quality of medication reviews, completion of appropriate referrals, consumer-reported experiences and whether services improve continuity after discharge. Confidence surveys are useful for identifying teaching needs but weak evidence of competence on their own. Programs should collect de-identified data, seek feedback from consumers and peers, and use findings to revise teaching rather than simply collect more surveys.

A practical pathway for educators and the profession

Education providers can begin by mapping existing learning against the capabilities required for mental health and addiction care. This work should involve pharmacists, students, consumers, carers, psychologists, social workers, alcohol and other drug specialists, Aboriginal health professionals and rural practitioners. Where gaps appear, educators can choose whether the answer is a new subject, longitudinal case work, simulation or a stronger community placement. A shared framework keeps programmes consistent without preventing local teams from responding to their own population needs.

Sustainable implementation requires more than enthusiastic curriculum meetings. It needs protected supervision time, funding for consumer contributors, rural preceptor support, appropriate clinical supervision and continuing professional development for practising pharmacists. Occupational health and safety arrangements, access to leave and flexible study options are particularly important for students and staff living with mental illness or substance use concerns. Services should also recognise jurisdictional differences in mental health regulation, medicines scheduling and treatment delivery rather than assuming a uniform national model.

The immediate call to action is to build one coordinated improvement pathway in every pharmacy education programme: identify a priority gap, co-design the learning, assess performance, fund the supervision and review the results with partner organisations. Pharmacy leaders, professional bodies, health services and policymakers then have a practical foundation for scaling what works. Mental health and addiction care will strengthen when pharmacists are educated to recognise, respond, refer and collaborate wherever the community reaches them.